Search jobs 13-May-2021 Down Syndrome Market To Hit Smashing Growth focusing on Top Companies | OPKO Health, Inc., LuMind IDSC Foundation, MIT Alana Center, H. Lundbeck A/S
The large scale Down Syndrome Market report identifies and analyses the emerging trends along with key drivers, challenges and opportunities in the industry. Moreover, this market report gives idea to clients about the market drivers and restraints extracted from SWOT analysis and also provides all the CAGR projections for the historic year 2018, base year 2019 and forecast period of 2020-2027. Market analysis included here gives an examination of various segments that are relied upon to witness the fastest development amid the estimate forecast frame. And not to mention, before giving it to the end users, all this information is assessed and validated by the market experts.
Ripple Software Achieves 96% Clinical Trial Retention
Share Article
Ripple Science Logo ANN ARBOR, Mich. (PRWEB) May 10, 2021 A white paper recently published by Ripple Science revealed that its flagship product, Ripple, empowered its customers to achieve >96% retention across all trials and 99% retention in 78.2% of completed trials, far outpacing industry averages.
Ripple Science is the leading provider of clinical trial software used by sites, CROs, and study sponsors to assist and automate the patient engagement workflow end-to-end, from first contact to study completion. Ripple has supported over 700 clinical trials involving over 240,000 patients globally, including a large number of Alzheimer s, dementia, and CNS trials where patient engagement is particularly challenging.
‘If you feel good, you work good’
TT Srinath reviews Sankarasubramanyan Ramamoorthy s book
When driving up the hill to the hill town, Kodaikanal, in Tamil Nadu, India, we pass a hamlet called ‘Perumal Malai,’ (Hill of God). In this hamlet is located Bodhi Zendo, a retreat centre, which encourages meditation practice according Buddhist tradition. The centre has been set up by a priest, Fr. Ama Samy.
In one of my several visits to the centre I met Fr. Ama Samy and requested him to help me re-craft my thought process which was then clouded with worry and anxiety.
After listening to me he took me to his library and offered me two books to read. One was a book titled ‘Feeling Good-The New Mood Therapy’ by David D Burns and the other was ‘Six Pillars of Self-esteem’ by Nathaniel Branden.
Published: Apr 20, 2021
Pittsburgh, April 20, 2021 (GLOBE NEWSWIRE) Cognition Therapeutics Inc., a clinical stage neuroscience company developing drugs that treat degenerative disorders by regulating cellular damage response pathways, announced that the board of directors has elected Jack A. Khattar chairman of the board. Mr. Khattar, the founder and CEO of Supernus Pharmaceuticals, was appointed in 2020 to serve as a member of the Cognition board of directors. He replaces former chairman, Robert J. Gailus, who has retired from the board of directors.
“Even in the short time that he has been a member of the board, Jack’s contributions have been significant. As chairman, we will draw more heavily on Jack’s expertise as we pursue a growing repertoire of indications and clinical plans,” stated President and CEO Lisa Ricciardi, “Bob’s retirement from the board comes after a remarkable tenure. He was one of Cognition’s earliest angel investors and continued to pro
WASHINGTON â In a push to combat the effect of the COVID-19 pandemicâs toll on mental health, U.S. Senate Majority Leader Chuck Schumer pushed the feds to âquick releaseâ $5 billion dollars he worked to include in the recently-passed American Rescue Plan (ARP) so that the funds can give New Yorkers â and the mental health providers they rely upon â the help theyâre asking for amid rising need.Â
Schumer said that, on average, three times more people than last year at this time report struggling with mental health symptoms like depression, anxiety, drug use and more. Schumer said that one of the biggest problems to beating these feelings and reclaiming mental health depends on timely access to care and overall access to care.